Local business? Support local news on PlanoWeekly.news

Back to Texas

Gilead to pay Texas $45 million to end Medicaid kickback suit over free nurses and billing help offered with 16 of its drugs

The drugmaker denies wrongdoing in the agreement, which settles a 2023 lawsuit in Harrison County. The attorney general's office says the programs steered prescriptions billed to Texas Medicaid.

Demarcus Ferris· AI-assisted, edited by Jake Team

October 22, 20262 min read

Medicaid healthcare policy - illustration, Jake Team LLC

Gilead Sciences will pay Texas $45 million to settle a lawsuit accusing the drugmaker of using free nursing services and insurance paperwork help to win prescriptions paid for by the state's Medicaid program, Attorney General Ken Paxton's office announced Thursday.

The case, The State of Texas ex rel. Health Choice Advocates, LLC v. Gilead Sciences, Inc., is in Harrison County District Court, where the attorney general's office says it sued in October 2023. The agreement says the case was started by Health Choice Advocates, which it calls the relator, with the state as a co-plaintiff.

The suit claimed that two Gilead programs amounted to illegal payments under the Texas Health Care Program Fraud Prevention Act and the state's anti-kickback law: one that offered nurses and education to prescribers and patients at no charge, and one in which the company took over reimbursement and administrative work that the suit said doctors' offices should handle themselves.

Both sides

In the attorney general's announcement, Paxton said doctors should prescribe based on a patient's best interest and that kickbacks put the integrity of the health care system at risk. His office said many of the affected prescriptions were billed to Medicaid.

The settlement agreement, posted with the announcement, states that it is a compromise of disputed facts and is not an admission of wrongdoing or liability by Gilead. It says the company has denied and continues to deny the allegations, including the names the state gave its programs, and that it maintains it has defenses to the claims.

It says that denial also extends to the company's ongoing patient support programs.

The terms

Gilead must wire the $45 million within 21 business days after the last signature, or interest begins accruing at 10% a year. The agreement labels $24,562,500 of the payment as restitution. The total also covers the state's legal costs and part of the relator's fees, with some of those fees to be paid by Gilead under a separate agreement.

Once the money arrives, the state and the relator are to dismiss the suit within three business days.

An attachment lists 16 Gilead products covered by the settlement, among them Biktarvy, Descovy, Epclusa, Genvoya, Harvoni, Sovaldi and Truvada. Signature pages show the attorney general's office and the Texas Health and Human Services Commission signed on Oct. 20.

The announcement says the office previously reached a similar kickback settlement with AstraZeneca.

Sources

texasattorneygeneral.gov

texasattorneygeneral.gov

Share

Demarcus Ferris· AI-assisted, edited by Jake Team

Demarcus Ferris writes about community life, schools, public safety, and local events in Plano.

Related Stories

More in Sport